Advertisement

Chronic Kidney Disease: Global Burden and Perspectives for Africa

  • Faical Jarraya
Chapter
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)

Abstract

The kidneys function as excretory, biosynthetic, and metabolic organs, is vital for maintaining normal physiology. Chronic kidney disease (CKD) and its terminal complication, end stage renal disease, may progress, undetected, until late stage kidney failure develops. At this point in the disease process, few opportunities exist to prevent its adverse outcomes, such as its association with high cardiovascular mortality and morbidity. CKD is caused mainly by common diseases, such as diabetes, hypertension, and chronic infections, and so it has become a global public health problem. CKD is costly. Preventing its occurrence by early diagnosis and optimized treatment of related causes, and preventing its progression to end stage renal failure may improve quality of life and benefit healthcare budgets. Such a strategy would be appropriate for developing countries, where CKD presents a significant challenge, which many of them, mainly in sub-Saharan Africa, are not equipped to handle.

Keywords

Chronic kidney disease Diabetes Hypertension Public health Developing countries Africa 

Notes

Conflict of Interest

None declared for the topic.

Funding: None.

Consent for publication: Not applicable.

Ethics approval: Not applicable.

References

  1. 1.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:5–14.CrossRefGoogle Scholar
  2. 2.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.CrossRefGoogle Scholar
  3. 3.
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.CrossRefGoogle Scholar
  4. 4.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerularfiltration rate. Ann Intern Med. 2009;150:604–12.CrossRefGoogle Scholar
  5. 5.
    Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59.CrossRefGoogle Scholar
  6. 6.
    Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34:795–808.CrossRefGoogle Scholar
  7. 7.
    Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166–74.CrossRefGoogle Scholar
  8. 8.
    Lee G. End-stage renal disease in the Asian-Pacific region. Semin Nephrol. 2003;23(1):107–14.CrossRefGoogle Scholar
  9. 9.
    Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005;366:1744–9.CrossRefGoogle Scholar
  10. 10.
    Rosa-Diez G, Gonzalez-Bedat M, Ferreiro A, García-García G, Fernandez-Cean J, Douthat W. Burden of end-stage renal disease (ESRD) in Latin America. Clin Nephrol Suppl. 2016;86:29–33.CrossRefGoogle Scholar
  11. 11.
    Davids MR, Eastwood JB, Selwood NH, Arogundade FA, Ashuntantang G, Benghanem Gharbi M, Jarraya F, MacPhee IA, McCulloch M, Plange-Rhule J, Swanepoel CR, Adu D. A renal registry for Africa: first steps. Clin Kidney J. 2016;9:162–7.CrossRefGoogle Scholar
  12. 12.
    Davids MR, Marais N, Jacobs JC. South African Renal Registry Annual Report 2015. Afr J Nephrol. 2017;20:201–13.Google Scholar
  13. 13.
    Soliman AR, Fathy A, Roshd D. The growing burden of end-stage renal disease in Egypt. Ren Fail. 2012;34:425–8.CrossRefGoogle Scholar
  14. 14.
    Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ, on behalf of the European Renal Registry Investigators. The 2008 ERA-EDTA registry annual report-a précis. NDT Plus. 2011;4:1–13.PubMedGoogle Scholar
  15. 15.
    Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–63.CrossRefGoogle Scholar
  16. 16.
    Perico N, Bravo RF, De Leon FR, Remuzzi G. Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant. 2009;24:1355–8.CrossRefGoogle Scholar
  17. 17.
    Jarraya F, Kammoun K, Mahfoudh H, Kammoun KH, Hachicha J. Management of arterial hypertension in Tunisia: the challenge of a developing country. Rev Med Suisse. 2012;8:1725–6. 1728-30.PubMedGoogle Scholar
  18. 18.
    Zafrani L, Kanfer A. Hypertension artérielle maligne. EMC (Elsevier Masson SAS, Paris), Cardiologie, 11-301-K-20-2007.Google Scholar
  19. 19.
    Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and metaanalysis. Hypertension. 2015;65:291–8.CrossRefGoogle Scholar
  20. 20.
    Mutemwa M, De Villiers A, Peer N, Matsha TE, Mukasa B, Mills EJ, Kengne AP. ISH NIA PS 03-07 an assessment of the prevalence, detection, treatment and control of hypertension in HIV infected patients receiving care across public HIV care facilities in the Western Cape Province of South Africa. J Hypertens. 2016;34:e282–3.CrossRefGoogle Scholar
  21. 21.
    Choukem SP, Kengne AP, Dehayem YM, Simo NL, Mbanya JC. Hypertension in people with diabetes in Sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract. 2007;77:293–9.CrossRefGoogle Scholar
  22. 22.
    Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185–92.CrossRefGoogle Scholar
  23. 23.
    Kanji Z, Powe CE, Wenger JB, et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol. 2011;22:2091–7.CrossRefGoogle Scholar
  24. 24.
    Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis. 2010;17:215–24.CrossRefGoogle Scholar
  25. 25.
    Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269–77.CrossRefGoogle Scholar
  26. 26.
    Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49(Pt.1):509–38.CrossRefGoogle Scholar
  27. 27.
    GBD 2015 Risk Factors Collaborations. Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–724.CrossRefGoogle Scholar
  28. 28.
    Bloom DE, Luca DL. The global demography of aging: facts, explanations, future. IZA Discussion Paper No. 10163. https://ssrn.com/abstract=2834213.
  29. 29.
    World Health Organization. Global nutrition policy review: what does it take to scale up nutrition action? Geneva: World Health Organization; 2013. p. 27. ISBN 978 92 4 150552 9.Google Scholar
  30. 30.
    Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, Mozaffarian D, Fawzi W, Willett W, Adami HO, Holmes MD. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011;40:885–901.CrossRefGoogle Scholar
  31. 31.
    Hajjem S. Statistique nationale sur les causes médicales de décès, Tunisia 2003. Tunis: National Institute For Public Health; 2007.Google Scholar
  32. 32.
    Atkins RC. The epidemiology of chronic kidney disease. Kidney Int Suppl. 2005;94:S14–8.CrossRefGoogle Scholar
  33. 33.
    Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003;14(Suppl 2):S131–8.CrossRefGoogle Scholar
  34. 34.
    Zhang L, Zuo L, Xu G, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007;22:1093–9.CrossRefGoogle Scholar
  35. 35.
    Kaze FF, Meto DT, Halle MP, Ngogang J, Kengne AP. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015;16:117.CrossRefGoogle Scholar
  36. 36.
    Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e174–81.CrossRefGoogle Scholar
  37. 37.
    Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–63.CrossRefGoogle Scholar
  38. 38.
    Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.CrossRefGoogle Scholar
  39. 39.
    Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, AlHabib KF, Kaur M, Kruger L, Teo K, Lanas F, Yusoff K, Oguz A, Gupta R, Yusufali AM, Bahonar A, Kutty R, Rosengren A, Mohan V, Avezum A, Yusuf R, Szuba A, Rangarajan S, Chow C, Yusuf S, PURE Study Investigators. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health. 2017;2:e411–9.CrossRefGoogle Scholar
  40. 40.
    Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, Ba SA, Kane A, Kramoh E, AnzouanKacou JB, Onwubere B, Cornick R, Sliwa K, Anisiuba B, Mocumbi AO, Ogola E, Awad M, Nel G, Otieno H, Toure AI, Kingue S, Kengne AP, Perel P, Adler A, Poulter N, Mayosi B, PASCAR Task Force on Hypertension. Roadmap to achieve 25% hypertension control in Africa by 2025. Glob Heart. 2018;13(1):45–59.  https://doi.org/10.1016/j.gheart.2017.06.001. pii: S2211-8160(17)30054-6.CrossRefPubMedGoogle Scholar
  41. 41.
    Leeder S, Raymond S, Greenberg H. A race against time: the challenge of cardiovascular disease in developing economies. New York: Columbia University Press; 2004.Google Scholar
  42. 42.
    Global Burden of Disease 2013 GFR Collaborators, CKD Prognosis Consortium, and Global Burden of Disease Genitourinary Expert Group. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167–79.CrossRefGoogle Scholar
  43. 43.
    Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354:997–9.CrossRefGoogle Scholar
  44. 44.
    Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Ambühl PM, Andrusev AM, Fuster EA, FEA M, Asberg A, Barbullushi M, Bonthuis M, Caskey FJ, de la Nuez PC, Cernevskis H, des Grottes JM, Garneata L, Golan E, Hemmelder MH, Ioannou K, Jarraya F, Kolesnyk M, Komissarov K, Lassalle M, Macario F, Mahillo-Duran B, Martın de Francisco AL, Palsson R, Pechter Ü, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Ogrizovic SS, MFS R, Spustova V, Stojceva-Taneva O, Traynor J, Massy ZA, Jager KJ. The European Renal Association—European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J. 2018;11:108–22.CrossRefGoogle Scholar
  45. 45.
    Hachicha J YS, Charfeddine K, Masmoud M, Jarraya F, Kharrat M, Kammoun K, Ben Hmida M, Mhiri MN, Hmida MJ, Karoui A, Ben Ammar MS, Ben Abdallah T, Chebil M. Living and cadaver donor transplant programs in the Maghreb. Saudi J Kidney Dis Transpl. 2013;24:150–6.CrossRefGoogle Scholar
  46. 46.
    Jarraya F. The need for dialysis registries in developing countries. http://www.era-edta.org/registry/newsletter17.htm.
  47. 47.
    Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.CrossRefGoogle Scholar
  48. 48.
    George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Global Health. 2017;2:e000256.CrossRefGoogle Scholar
  49. 49.
    Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65:281–393.PubMedGoogle Scholar
  50. 50.
    Mathew T, Corso O. Review article: early detection of chronic kidney disease in Australia: which way to go? Nephrology. 2009;14:367–73.CrossRefGoogle Scholar
  51. 51.
    Bang H, Vupputuri S, Shoham DA, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–81.CrossRefGoogle Scholar
  52. 52.
    de Almeida EA, Lavinas C, Teixeira C, et al. Evaluation of an instrument for screening patients at risk for chronic kidney disease: testing SCORED (SCreening for Occult REnal Disease) in a Portuguese population. Kidney Blood Press Res. 2012;35:568–72.CrossRefGoogle Scholar
  53. 53.
    Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63:789–97.CrossRefGoogle Scholar
  54. 54.
    Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4:e307–19.CrossRefGoogle Scholar
  55. 55.
    Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103:150–60.CrossRefGoogle Scholar
  56. 56.
    Mullan F. The metrics of the physician brain drain. N Engl J Med. 2005;353:1810–8.CrossRefGoogle Scholar
  57. 57.
    Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol. 2010;74(suppl1):S129–33.PubMedGoogle Scholar
  58. 58.
    Field M. Addressing the global shortage of nephrologists. Nat Clin Pract Nephrol. 2008;4:583.CrossRefGoogle Scholar
  59. 59.
    Ashuntantang G, Osafo C, Olowu WA, Arogundade F, Niang A, Porter J, Naicker S, Luyckx VA. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2017;5:e408–17.CrossRefGoogle Scholar
  60. 60.
    Halle MP, Ashuntantang G, Kaze FF, Takongue C, Kengne AP. Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala General Hospital in Cameroon. BMC Nephrol. 2016;17:165.CrossRefGoogle Scholar
  61. 61.
    Fouda H, Ashuntantang G, Kaze F, Halle MP. Survival among chronic hemodialysed patients in Cameroon. Pan Afr Med J. 2017;26:97.CrossRefGoogle Scholar
  62. 62.
    Ulasi I, Ijoma Chinwuba K. The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med. 2010;2010:501957.CrossRefGoogle Scholar
  63. 63.
    Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation, Geneva, 28 January–1 February 2002. (WHO technical report series; 916). ISBN 92 4 120916 X.Google Scholar
  64. 64.
    The Low Birth Weight and Nephron Number Working Group. The impact of kidney development on the life course: a consensus document for action. Nephron Clin Pract. 2017;136:3–49.PubMedCentralGoogle Scholar
  65. 65.
    Jafar TH. The growing burden of chronic kidney disease in Pakistan. N Engl J Med. 2006;354:995–7.CrossRefGoogle Scholar
  66. 66.
    Chugh KS, Jha V, Chugh S. Economics of dialysis and renal transplantation in the developing world. Transplant Proc. 1999;31:3275–7.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Faical Jarraya
    • 1
  1. 1.Research Unit 12ES14 and Nephrology DepartmentHedi Chaker University Hospital, Faculty of Medicine, Sfax UniversitySfaxTunisia

Personalised recommendations